SCHULER JACK W — SEC insider filings
SEC reporting owner CIK 1021412. 109 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers the 50 most recent of 109 filings on record, filed 2023-02-01 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 33 legs across 26 filings — 12,087,113 shares, $11,627,509 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): 80 legs across 9 filings — 1,060,701 shares, $1,448,209 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 30.
- Largest priced transaction: purchase of 3,488,372 shares @ $0.43 ($1,500,000) in BIODESIX INC, filed 2025-09-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIODESIX INC (BDSX) | 10% owner | 24 | 26 legs · 9,436,374 sh · $9,030,311 | — | 8 |
| YIELD10 BIOSCIENCE, INC. (YTEN) | 10% owner | 8 | 2 legs · 1,100,570 sh · $1,497,249 | 48 legs · 430,630 sh · $659,765 | 2 |
| Aspira Women's Health Inc. (AWHL) | 10% owner | 6 | 5 legs · 1,550,169 sh · $1,099,950 | — | 5 |
| SOLENO THERAPEUTICS INC (SLNO) | 10% owner | 2 | — | 31 legs · 430,071 sh · $474,444 | — |
| Accelerate Diagnostics, Inc (AXDX) | Director, 10% owner | 10 | — | 1 leg · 200,000 sh · $314,000 | 15 |
Insider filings — SCHULER JACK W
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | BIODESIX INC (BDSX) | Purchase (P): 100,000 @ $10.02 | EDGAR |
| 2026-08-13 | 4 | BIODESIX INC (BDSX) | Purchase (P): 15,000 @ $24.47 | EDGAR |
| 2026-08-12 | 4 | BIODESIX INC (BDSX) | Purchase (P): 13,900 @ $24.25 · Purchase (P): 13,700 @ $24.01 | EDGAR |
| 2026-06-09 | 4 | Aspira Women's Health Inc. (AWHL) | Purchase (P): 222,222 @ $0.45 · Purchase (P): 300,000 (derivative) @ $0 | EDGAR |
| 2026-01-27 | 4 | BIODESIX INC (BDSX) | Purchase (P): 80,000 @ $11.81 · Purchase (P): 20,000 @ $11.80 | EDGAR |
| 2026-01-26 | 4 | BIODESIX INC (BDSX) | Purchase (P): 82,465 @ $10.96 | EDGAR |
| 2025-09-23 | 4 | BIODESIX INC (BDSX) | Purchase (P): 142,045 @ $7.04 | EDGAR |
| 2025-09-19 | 4 | BIODESIX INC (BDSX) | Purchase (P): 15,317 @ $6.04 · Purchase (P): 3,056 @ $6.17 | EDGAR |
| 2025-09-19 | 4 | Aspira Women's Health Inc. (AWHL) | Purchase (P): 1,111,111 @ $0.45 · Purchase (P): 833,333 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | BIODESIX INC (BDSX) | Purchase (P): 3,488,372 @ $0.43 | EDGAR |
| 2025-05-20 | 4 | BIODESIX INC (BDSX) | Purchase (P): 4,000,000 @ $0.27 · Purchase (P): 723,239 @ $0.34 | EDGAR |
| 2025-03-10 | 4 | Aspira Women's Health Inc. (AWH) | Purchase (P) @ $200,000 | EDGAR |
| 2024-12-03 | 4 | Accelerate Diagnostics, Inc (AXDX) | Sale (S): 200,000 @ $1.57 | EDGAR |
| 2024-11-22 | 4 | BIODESIX INC (BDSX) | Purchase (P): 100,000 @ $1.23 | EDGAR |
| 2024-11-21 | 4 | BIODESIX INC (BDSX) | Purchase (P): 200,000 @ $1.17 | EDGAR |
| 2024-11-06 | 4 | BIODESIX INC (BDSX) | Purchase (P): 100,253 @ $1.36 | EDGAR |
| 2024-07-11 | 4 | Aspira Women's Health Inc. (AWH) | Purchase (P): 6,536 · Purchase (P): 6,536 (derivative) | EDGAR |
| 2024-07-01 | 4 | Accelerate Diagnostics, Inc (AXDX) | Option exercise (M): 4,737 @ $0 · Option exercise (M): 4,737 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Aspira Women's Health Inc. (AWH) | Purchase (P): 28,500 · Purchase (P): 28,500 (derivative) | EDGAR |
| 2024-05-30 | 4 | Accelerate Diagnostics, Inc (AXDX) | Option exercise (M): 7,894 @ $0 · Option exercise (M): 7,894 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | BIODESIX INC (BDSX) | Option exercise (M): 86,960 · Grant/award (A): 46,686 (derivative) @ $0 · Grant/award (A): 37,050 (derivative) @ $0 · Option exercise (M): 2,174 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | Accelerate Diagnostics, Inc (AXDX) | Grant/award (A): 1,560,694 · Grant/award (A): 1,560,694 (derivative) | EDGAR |
| 2024-05-21 | 4 | Accelerate Diagnostics, Inc (AXDX) | Grant/award (A): 66,667 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | YIELD10 BIOSCIENCE, INC. (YTEN) | Sale (S): 36,000 @ $0.20 | EDGAR |
| 2024-04-09 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 2,174 (derivative) @ $46 | EDGAR |
| 2024-01-25 | 4 | Accelerate Diagnostics, Inc (AXDX) | Grant/award (A): 1,156,069 · Grant/award (A): 1,156,069 (derivative) | EDGAR |
| 2024-01-03 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 105,389 (derivative) @ $0 | EDGAR |
| 2023-12-20 | 4 | YIELD10 BIOSCIENCE, INC. (YTEN) | Sale (S): 36,000 @ $0.21 | EDGAR |
| 2023-12-11 | 4 | YIELD10 BIOSCIENCE, INC. (YTEN) | Sale (S): 35,000 @ $0.24 | EDGAR |
| 2023-10-10 | 4 | YIELD10 BIOSCIENCE, INC. (YTEN) | Purchase (P): 765,000 @ $0.65 · Purchase (P): 765,000 (derivative) | EDGAR |
| 2023-10-06 | 4 | YIELD10 BIOSCIENCE, INC. (YTEN) | Sale (S): 41,399 @ $0.31 · Sale (S): 10,670 @ $0.30 · Sale (S): 37,931 @ $0.30 | EDGAR |
| 2023-08-23 | 4 | BIODESIX INC (BDSX) | Purchase (P): 32,556 @ $1.64 · Purchase (P): 8,307 @ $1.67 · Purchase (P): 87,500 @ $1.71 | EDGAR |
| 2023-08-11 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 9,989,506 @ $1.62 | EDGAR |
| 2023-07-25 | 4 | Aspira Women's Health Inc. (AWH) | Purchase (P): 181,800 @ $2.75 | EDGAR |
| 2023-06-29 | 4 | Accelerate Diagnostics, Inc (AXDX) | Grant/award (A): 236,842 (derivative) @ $0 | EDGAR |
| 2023-06-20 | 4 | Accelerate Diagnostics, Inc (AXDX) | Grant/award (A): 4,878,048 @ $0.82 · Grant/award (A): 34,321,163 @ $1.06 | EDGAR |
| 2023-06-01 | 4 | BIODESIX INC (BDSX) | Purchase (P): 11,849 @ $1.36 · Purchase (P): 14,792 @ $1.35 | EDGAR |
| 2023-06-01 | 4 | Accelerate Diagnostics, Inc (AXDX) | Grant/award (A): 78,947 (derivative) @ $0 | EDGAR |
| 2023-06-01 | 4 | Accelerate Diagnostics, Inc (AXDX) | Option exercise (M): 75,949 @ $0 · Option exercise (M): 75,949 (derivative) @ $0 | EDGAR |
| 2023-05-30 | 4 | BIODESIX INC (BDSX) | Purchase (P): 52,508 @ $1.36 | EDGAR |
| 2023-05-26 | 4 | BIODESIX INC (BDSX) | Purchase (P): 35,308 @ $1.25 | EDGAR |
| 2023-05-25 | 4 | BIODESIX INC (BDSX) | Purchase (P): 56,782 @ $1.15 | EDGAR |
| 2023-05-25 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 28,873 (derivative) @ $0 | EDGAR |
| 2023-05-24 | 4 | BIODESIX INC (BDSX) | Purchase (P): 29,425 @ $1.11 | EDGAR |
| 2023-05-15 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Sale (S): 400 @ $1.52 · Sale (S): 8,842 @ $1.26 · Sale (S): 9,100 @ $1.16 · Sale (S): 10,000 @ $1.08 · Sale (S): 10,000 @ $1 · Sale (S): 10,000 @ $0.99 · +24 more | EDGAR |
| 2023-05-15 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Sale (S): 10,000 @ $0.91 | EDGAR |
| 2023-05-09 | 4 | YIELD10 BIOSCIENCE, INC. (YTEN) | Sale (S): 4,901 @ $2.96 · Sale (S): 200 @ $2.90 · Sale (S): 900 @ $2.96 · Sale (S): 1,200 @ $2.85 · Sale (S): 3,000 @ $2.88 · Sale (S): 3,000 @ $3.20 · +24 more | EDGAR |
| 2023-05-09 | 4 | YIELD10 BIOSCIENCE, INC. (YTEN) | Sale (S): 7,000 @ $2.06 · Sale (S): 7,000 @ $1.96 · Sale (S): 3,504 @ $1.91 · Sale (S): 5,300 @ $1.91 · Sale (S): 10,152 @ $1.88 · Sale (S): 4,292 @ $1.80 · +6 more | EDGAR |
| 2023-05-09 | 4 | YIELD10 BIOSCIENCE, INC. (YTEN) | Purchase (P): 335,570 @ $2.98 · Purchase (P): 335,570 (derivative) @ $2.98 | EDGAR |
| 2023-02-01 | 4 | BIODESIX INC (BDSX) | Purchase (P): 10,000 @ $2.41 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1021412 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs